Physician profile
Todd Mark Rumans
NPI 1124097209
$971.89
in general payments reported to CMS, 2019-2025
21 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $75.56 · 2021: $89.42 · 2022: $30.08 · 2023: $124 · 2024: $281 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $374.47 | 2023-2025 | Puraply, Puraply Wound Matrix, Puraply Am |
| Stryker Corporation | $133.83 | 2019-2021 | |
| Glaxosmithkline, LLC. | $70.80 | 2023-2025 | Nucala |
| Kci USA, INC. | $57.85 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo |
| Urogen Pharma, INC. | $45.79 | 2025 | |
| Inspire Medical Systems, INC. | $31.28 | 2025 | Inspire |
| Tela Bio, INC. | $30.56 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| 180 Medical, INC. | $27.00 | 2024 | Gentlecath Glide |
| Olympus America INC. | $19.83 | 2019 | |
| Philips North America LLC | $19.30 | 2024 | (6536) Phoenix |
| Davol INC. | $18.38 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.63 | 2022 | |
| Sumitomo Pharma America, INC. | $17.62 | 2025 | Orgovyx |
| Covidien LP | $16.78 | 2019 | |
| Teleflex LLC | $15.12 | 2025 | Barrigel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $13.39 | 2023 | Axonics |
| Smith+Nephew, INC. | $13.07 | 2020 | |
| Innocoll Pharmaceuticals Limited | $12.45 | 2022 | |
| Intersect Ent, INC. | $12.29 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $12.25 | 2019 | |
| Amgen INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Rumans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.